Local biotech exec joins Dutch VC firm that plans to open first U.S. office in Boston
By Hannah Green The former CEO of Dyne Therapeutics Inc. has joined Forbion as the life sciences venture capital firm announced plans to expand its U.S. presence by opening a Boston office. Josh Brumm, formerly of Dyne and a newly named general partner at Forbion, said the Boston office “really does have a chance to impact the […]